Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP was delisted on the 13th of August, 2018.
33 hedge funds and large institutions have $19.8M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 6 closing their positions.
143% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 7
18% more capital invested
Capital invested by funds: $16.8M → $19.8M (+$2.99M)
13% less funds holding
Funds holding: 38 → 33 (-5)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MERSOM
Municipal Employees' Retirement System of Michigan
Lansing,
Michigan
|
+$1.06M |
| 2 |
Renaissance Technologies
New York
|
+$412K |
| 3 |
BlackRock
New York
|
+$380K |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
+$246K |
| 5 |
JAM
JW Asset Management
Miami Beach,
Florida
|
+$173K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$330K |
| 2 |
GF
Gabelli Funds
Rye,
New York
|
-$253K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$156K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$112K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$86K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIM
26
Acrospire Investment Management
Chicago,
Illinois
| $43K | +$30.5K | +6,818 | +425% |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| $35K | -$166 | -37 | -0.5% |
|
28
UBS Group
Zurich,
Switzerland
| $11K | +$9.13K | +2,040 | +1,427% |
|
29
Envestnet Asset Management
Chicago,
Illinois
| $5K | +$4.47K | +1,000 | +100,000% |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| $3K | +$1.77K | +396 | +241% |
|
31
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $2K | -$282 | -63 | -14% |
|
|
FWM
32
Focused Wealth Management
Newburgh,
New York
| $1K | – | – | – |
|
|
GF
33
Gabelli Funds
Rye,
New York
| – | -$253K | -53,182 | Closed |
|
|
VKH
34
Virtu KCG Holdings
New York
| – | -$112K | -23,544 | Closed |
|
|
35
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$86K | -18,300 | Closed |
|
36
Walleye Trading
New York
| – | -$15 | -3,200 | Closed |
|
|
ECM
37
Estabrook Capital Management
New York
| – | -$7.13K | -1,500 | Closed |
|
38
Barclays
London,
United Kingdom
| – | -$2K | -497 | Closed |
|
JNP Hedge Fund Activity: Q2 2017 in Review
33 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Juniper Pharmaceuticals, Inc. Common Stock (JNP) for Q2 2017, worth a combined $19.8M — up 18% from $16.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of JNP and 1 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 17 added.
The largest buyer was Municipal Employees' Retirement System of Michigan, opening a new position worth an estimated $1.06M. The largest seller was Vanguard Group, cutting an estimated $330K.
- 33 institutional investors held Juniper Pharmaceuticals, Inc. Common Stock (JNP) as of Q2 2017, down from 38 in Q1 2017.
- Funds reported $19.8M of Juniper Pharmaceuticals, Inc. Common Stock stock for Q2 2017, up 18% quarter-over-quarter.
- 1 fund opened new Juniper Pharmaceuticals, Inc. Common Stock positions in Q2 2017 and 6 closed out, a net change of -5 holders.
- The largest Juniper Pharmaceuticals, Inc. Common Stock buyer in Q2 2017 was Municipal Employees' Retirement System of Michigan, an estimated $1.06M added.
- The largest Juniper Pharmaceuticals, Inc. Common Stock seller in Q2 2017 was Vanguard Group, an estimated $330K sold.
Based on aggregated 13F filings for Q2 2017.